Alyftrek 10-50-125 MG tablet 14S
Ended Awarded
- Contract number
- SPE2DB25FX2DN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,987
Award facts
- Contract value 100% obligated
- $41,986.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $41,986.64 by the Defense Logistics Agency on August 26, 2025, for ALYFTREK 10-50-125 mg tablets in quantities of 14 units. The contract is structured as a firm fixed-price delivery order without set-aside designation, with an ultimate completion date of August 27, 2025, and performance at the vendor's Park Ridge facility. This award represents a continuation of DMS Pharmaceutical Group's ongoing pharmaceutical supply relationship with the Department of Defense through the federal procurement system.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The IDC, established under the SPE2DB program, enables the Defense Logistics Agency to procure a comprehensive range of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support medical supply needs across military health facilities. DMS Pharmaceutical Group has demonstrated a robust portfolio of federal contract awards supplying specialized pharmaceutical products ranging from contraceptive devices to oncology treatments, positioning the company as a critical supplier within the federal pharmaceutical supply chain for Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FX2DN?
SPE2DB25FX2DN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FX2DN worth?
The government has obligated $41,987 on SPE2DB25FX2DN.
Is contract SPE2DB25FX2DN an order under another contract?
Yes. SPE2DB25FX2DN is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX2DN competed?
The extent of competition for SPE2DB25FX2DN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award